Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, argenx SE (ARGX) has a Wall Street consensus price target of $1026.71, based on estimates from 35 covering analysts. With the stock currently trading at $766.92, this represents a potential upside of +33.9%. The company has a market capitalization of $47.46B.
Analyst price targets range from a low of $858.00 to a high of $1317.00, representing a 45% spread in expectations. The median target of $968.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 30 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ARGX trades at a trailing P/E of 60.0x and forward P/E of 25.6x. Analysts expect EPS to grow +113.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $2585.88, with bear and bull scenarios of $124932.36 and $441.36 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ARGX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for ARGX is $1026.71, representing 33.9% upside from the current price of $766.92. With 35 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARGX has a consensus rating of "Buy" based on 35 Wall Street analysts. The rating breakdown is predominantly bullish, with 30 Buy/Strong Buy ratings. The consensus 12-month price target of $1026.71 implies 33.9% upside from current levels.
ARGX trades at a forward P/E of 25.5737x, representing a moderate valuation. With analysts targeting $1026.71 (33.9% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $1317 for ARGX, while the most conservative target is $858. The consensus of $1026.71 represents the median expectation. Our quantitative valuation model projects a bull case target of $441 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ARGX is heavily covered by Wall Street, with 35 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 29 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARGX stock forecast based on 35 Wall Street analysts shows a consensus price target of $1026.71, with estimates ranging from $858 (bear case) to $1317 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $2586, with bear/bull scenarios of $124932/$441.
Our quantitative valuation model calculates ARGX's fair value at $2586 (base case), with a bear case of $124932 and bull case of $441. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
ARGX trades at a forward P/E ratio of 25.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 60.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ARGX, with a "Buy" consensus rating and $1026.71 price target (33.9% upside). 30 of 35 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARGX analyst price targets range from $858 to $1317, a 45% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $1026.71 consensus represents the middle ground. Our model's $124932-$441 range provides an independent fundamental perspective.